GATA2 gene mutation can indicate risk of blood cancers

09/5/2011 | Sydney Morning Herald (Australia), The

Australian researchers have found that mutations in the GATA2 gene could indicate that a person is more vulnerable to developing blood cancers such as myelodysplastic syndrome and acute myeloid leukemia. The gene influences the functions of genes involved in the production of white blood cells. A clinical trial is being undertaken in the U.S. to explore treatment options.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX